# Translation MRC Impact Acceleration Awards

**Funder:** MRC (UKRI)
**Budget:** £50k–£300k FEC (80% funded, i.e. up to £240k awarded)
**Deadline:** 11 November 2026 (4:00pm UK time)
**Duration:** 6–18 months
**Consortium:** No
**Application:** Single stage
**Eligible countries:** GB
**Official call:** https://www.ukri.org/opportunity/ukri-translation-mrc-impact-acceleration-awards/
**Last verified:** 19 July 2026

## Eligibility & scope

Academically led translational single-step projects generating critical preliminary data for new medicines, devices, diagnostics or other medical interventions. UK research organisations eligible as lead; international researchers may join as project co-leads. Businesses and non-approved charities cannot lead. No clinical trials or fundamental research. Proposals must be submitted in English via UKRI Funding Service.

## Summary

The MRC Translation Impact Acceleration Awards fund £50k-£300k (80% funded) for academically led translational research projects generating critical preliminary data to advance new medicines, devices, diagnostics, or medical interventions toward clinical development. Eligible applicants are researchers at UK institutions; international researchers may join as co-leads, but businesses and non-approved charities cannot be lead applicants. Projects run 6-18 months and exclude clinical trials and fundamental research.

## Who should apply

- Researchers at UK academic institutions or approved research organisations
- Translational teams with preliminary data ready to advance toward next development stage
- Projects on new medicines, devices, diagnostics, or medical interventions (no fundamental research or clinical trials)
- Teams willing to work with international co-leads, but lead organisation must be UK-based

## Key dates

- Deadline: 11 November 2026, 4:00 PM UK time
- Single-stage written evaluation
- Project duration 6-18 months

## Tips for applicants

- Lead with preliminary data and the critical gap it bridges, reviewers expect near-commercialisation readiness, not exploratory science.
- Name a clear translational pathway (e.g. regulatory milestones, IP strategy, industry route); vague 'future development' language scores poorly.
- International co-leads strengthen the proposal if they add specific technical or clinical depth; include a co-lead letter confirming their role and commitment.

## Frequently asked questions

### How much does the MRC Translation Impact Acceleration Award fund?

Up to £300,000 (80% funded, so up to £240,000 awarded); the funder covers 80% of Full Economic Cost.

### What is the project duration for the MRC Translation Impact Acceleration Award?

Projects run between 6 and 18 months, depending on scope and the preliminary data package.

### Can international researchers lead an MRC Translation Impact Acceleration Award?

No; the lead organisation must be a UK research institution. International researchers may participate as named project co-leads.

### What types of research are ineligible for the MRC Translation Impact Acceleration Award?

Clinical trials, fundamental research, and proposals led by businesses or non-approved charities are not eligible.

### When is the deadline for the MRC Translation Impact Acceleration Award?

The deadline is 11 November 2026 at 4:00 PM UK time; applications are submitted via the UKRI Funding Service.

---

Source: [The Great Grantsby](https://grantsby.eu/grants/mrc-ukri-translation-mrc-impact-acceleration-awards-2026-11) — EU grant monitoring for academic researchers. Always verify details on the funder's website before applying.

**See which EU calls match your profile.** [Preview your matches in 30 seconds, no signup](https://grantsby.eu/demo?ref=llm_grant_md).